0001996810-26-000068.txt : 20260429 0001996810-26-000068.hdr.sgml : 20260429 20260429201516 ACCESSION NUMBER: 0001996810-26-000068 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260427 FILED AS OF DATE: 20260429 DATE AS OF CHANGE: 20260429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Strazik Scott CENTRAL INDEX KEY: 0001763642 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41966 FILM NUMBER: 26919329 MAIL ADDRESS: STREET 1: ONE FINANCIAL CENTER STREET 2: SUITE 3700 CITY: BOSTON STATE: MA ZIP: 02111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GE Vernova Inc. CENTRAL INDEX KEY: 0001996810 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC & OTHER ELECTRICAL EQUIPMENT (NO COMPUTER EQUIP) [3600] ORGANIZATION NAME: 04 Manufacturing EIN: 461480316 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 58 CHARLES STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-674-7555 MAIL ADDRESS: STREET 1: 58 CHARLES STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 FORMER COMPANY: FORMER CONFORMED NAME: GE Vernova LLC DATE OF NAME CHANGE: 20231010 4 1 wk-form4_1777508114.xml FORM 4 X0609 4 2026-04-27 0 0001996810 GE Vernova Inc. GEV 0001763642 Strazik Scott false 58 CHARLES STREET CAMBRIDGE MA 02141 1 1 0 0 CEO & President 0 Common stock, par value $0.01 per share 2026-04-27 4 M 0 21754 149.78 A 153800 D Common stock, par value $0.01 per share 2026-04-27 4 F 0 12273 1114.88 D 141527 D Common stock, par value $0.01 per share 2026-04-27 4 M 0 22742 92.13 A 164269 D Common stock, par value $0.01 per share 2026-04-27 4 F 0 11987 1115.60 D 152282 D Common stock, par value $0.01 per share 2353 I By 401(k) Common stock, par value $0.01 per share 1287 I By spouse's 401(k) Employee Stock Option (right to buy) 149.78 2026-04-27 4 M 0 21754 149.78 D 2026-09-30 Common stock, par value $0.01 per share 21754 0 D Employee Stock Option (right to buy) 92.13 2026-04-27 4 M 0 22742 92.13 D 2027-11-17 Common stock, par value $0.01 per share 22742 0 D The options vested in five installments on September 30, 2017, 2018, 2019, 2020 and 2021. The options exercise was executed in anticipation of the September 30, 2026 expiration date on a net settlement basis and did not result in an open market transaction. The options vested in five installments on November 17, 2018, 2019, 2020, 2021 and 2022. The options exercise was executed in anticipation of the November 17, 2027 expiration date on a net settlement basis and did not result in an open market transaction. /s/ Richmond Glasgow, VP, Chief Corporate Counsel & Deputy Secretary, as attorney-in-fact 2026-04-29